GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)
India · Delayed Price · Currency is INR 2,700.00
+40.30 (1.52%)
Oct 1, 2025, 3:30 PM IST
NSE:GLAXO Market Cap
NSE:GLAXO has a market cap or net worth of 456.47 billion as of October 2, 2025. Its market cap has decreased by -7.18% in one year.
Market Cap
456.47B
Enterprise Value
431.59B
Revenue
37.40B
Ranking
n/a
PE Ratio
48.04
Stock Price
2,700.00
Market Cap Chart
Since October 25, 2001, NSE:GLAXO's market cap has increased from 19.14B to 456.47B, an increase of 2,284.91%. That is a compound annual growth rate of 14.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2025 | 456.47B | 19.65% |
| Dec 31, 2024 | 381.50B | 18.69% |
| Dec 29, 2023 | 321.43B | 43.86% |
| Dec 30, 2022 | 223.43B | -25.08% |
| Dec 31, 2021 | 298.24B | 8.46% |
| Dec 31, 2020 | 274.98B | 0.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,925.79B |
| Divi's Laboratories | 1,515.83B |
| Cipla | 1,222.15B |
| Apollo Hospitals Enterprise | 1,069.90B |
| Mankind Pharma | 1,006.97B |
| Zydus Lifesciences | 997.33B |
| Fortis Healthcare | 747.14B |
| Alkem Laboratories | 652.77B |